$364 Million is the total value of Ghost Tree Capital, LLC's 52 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 64.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SER TRcall | $40,620,000 | – | 300,000 | +100.0% | 11.17% | – |
| RAPT | New | RAPT THERAPEUTICS INC | $18,120,000 | – | 570,000 | +100.0% | 4.98% | – |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $17,759,000 | +2.1% | 135,000 | 0.0% | 4.88% | +19.4% | |
| FATE | FATE THERAPEUTICS INC | $16,056,000 | +5.3% | 185,000 | 0.0% | 4.41% | +23.1% | |
| XENE | XENON PHARMACEUTICALS INC | $15,827,000 | +4.0% | 850,000 | 0.0% | 4.35% | +21.7% | |
| ARVN | ARVINAS INC | $15,785,000 | +16.5% | 205,000 | 0.0% | 4.34% | +36.2% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $15,024,000 | -42.8% | 875,000 | -25.5% | 4.13% | -33.1% |
| KURA | Buy | KURA ONCOLOGY INC | $14,595,000 | -14.0% | 700,000 | +16.7% | 4.01% | +0.6% |
| COGT | COGENT BIOSCIENCES INC | $12,976,000 | -7.6% | 1,600,000 | 0.0% | 3.57% | +8.0% | |
| Sell | TRILLIUM THERAPEUTICS INC | $12,125,000 | -42.1% | 1,250,000 | -35.9% | 3.33% | -32.3% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $11,709,000 | -26.0% | 450,000 | -10.0% | 3.22% | -13.5% |
| BIIB | Buy | BIOGEN INC | $11,254,000 | +101.1% | 32,500 | +62.5% | 3.09% | +135.3% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $9,530,000 | +85.0% | 285,000 | +14.0% | 2.62% | +116.5% |
| MRTX | MIRATI THERAPEUTICS INC | $8,077,000 | -5.7% | 50,000 | 0.0% | 2.22% | +10.3% | |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $7,172,000 | – | 275,000 | +100.0% | 1.97% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $6,982,000 | -27.6% | 180,000 | -10.0% | 1.92% | -15.3% |
| ALDX | Sell | ALDEYRA THERAPEUTICS INC | $6,798,000 | -12.0% | 600,000 | -7.7% | 1.87% | +3.0% |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $6,540,000 | -16.7% | 1,000,000 | +6.5% | 1.80% | -2.5% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $6,402,000 | +27.7% | 350,000 | +16.7% | 1.76% | +49.4% |
| STSA | SATSUMA PHARMACEUTICALS INC | $6,375,000 | +24.1% | 904,225 | 0.0% | 1.75% | +45.2% | |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $6,300,000 | -28.6% | 2,000,000 | -51.7% | 1.73% | -16.5% |
| MRSN | MERSANA THERAPEUTICS INC | $6,111,000 | -16.1% | 450,000 | 0.0% | 1.68% | -1.8% | |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $6,072,000 | +35.5% | 200,000 | +33.3% | 1.67% | +58.5% |
| EPIX | Buy | ESSA PHARMA INC | $5,928,000 | +16.6% | 207,500 | +18.6% | 1.63% | +36.4% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $5,536,000 | -61.6% | 125,000 | -61.5% | 1.52% | -55.1% |
| HLXA | HELIX ACQUISITION CORP | $5,175,000 | +1.1% | 500,000 | 0.0% | 1.42% | +18.3% | |
| GLPG | New | GALAPAGOS NVspon adr | $5,167,000 | – | 75,000 | +100.0% | 1.42% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $4,927,000 | – | 170,000 | +100.0% | 1.35% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $4,586,000 | – | 243,309 | +100.0% | 1.26% | – |
| ISEE | Sell | IVERIC BIO INC | $4,575,000 | -34.2% | 725,000 | -35.6% | 1.26% | -23.0% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $4,390,000 | -71.0% | 250,000 | -58.3% | 1.21% | -66.0% |
| CBIO | CATALYST BIOSCIENCES INC | $4,330,000 | -14.1% | 1,000,000 | 0.0% | 1.19% | +0.4% | |
| CTIC | Buy | CTI BIOPHARMA CORP | $4,000,000 | +83.2% | 1,600,000 | +113.3% | 1.10% | +114.4% |
| SRRA | SIERRA ONCOLOGY INC | $3,894,000 | +13.0% | 200,000 | 0.0% | 1.07% | +32.1% | |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $3,529,000 | – | 125,000 | +100.0% | 0.97% | – |
| PCVX | New | VAXCYTE INC | $3,264,000 | – | 145,000 | +100.0% | 0.90% | – |
| IMUX | IMMUNIC INC | $3,249,000 | -23.1% | 265,000 | 0.0% | 0.89% | -10.1% | |
| KDMN | Buy | KADMON HLDGS INC | $3,096,000 | +32.6% | 800,000 | +33.3% | 0.85% | +55.0% |
| FOLD | AMICUS THERAPEUTICS INC | $2,555,000 | -2.4% | 265,000 | 0.0% | 0.70% | +14.1% | |
| IMVT | New | IMMUNOVANT INCcall | $2,114,000 | – | 200,000 | +100.0% | 0.58% | – |
| CRIS | Sell | CURIS INC | $1,994,000 | -58.6% | 247,124 | -41.9% | 0.55% | -51.5% |
| CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,922,000 | – | 75,000 | +100.0% | 0.53% | – |
| CMRX | CHIMERIX INC | $1,600,000 | -17.0% | 200,000 | 0.0% | 0.44% | -2.9% | |
| MRUS | New | MERUS N V | $1,580,000 | – | 75,000 | +100.0% | 0.43% | – |
| ELEV | New | ELEVATION ONCOLOGY INC | $1,357,000 | – | 100,000 | +100.0% | 0.37% | – |
| PRVB | New | PROVENTION BIO INCput | $1,265,000 | – | 150,000 | +100.0% | 0.35% | – |
| CASI | CASI PHARMACEUTICALS INC | $1,008,000 | -35.4% | 650,000 | 0.0% | 0.28% | -24.5% | |
| OTIC | OTONOMY INC | $1,004,000 | -12.5% | 450,000 | 0.0% | 0.28% | +2.2% | |
| LRMR | New | LARIMAR THERAPEUTICS INC | $982,000 | – | 100,000 | +100.0% | 0.27% | – |
| MRNA | New | MODERNA INC | $940,000 | – | 4,000 | +100.0% | 0.26% | – |
| PRVB | New | PROVENTION BIO INC | $843,000 | – | 100,000 | +100.0% | 0.23% | – |
| DNAY | New | CODEX DNA INC | $770,000 | – | 35,000 | +100.0% | 0.21% | – |
| FREQ | Exit | FREQUENCY THERAPEUTICS INCput | $0 | – | -100,000 | -100.0% | -0.22% | – |
| APVO | Exit | APTEVO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.36% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEWput | $0 | – | -100,000 | -100.0% | -0.48% | – |
| DTIL | Exit | PRECISION BIOSCIENCES INC | $0 | – | -200,000 | -100.0% | -0.49% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -30,000 | -100.0% | -0.53% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -17,500 | -100.0% | -0.75% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -250,000 | -100.0% | -0.94% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -125,000 | -100.0% | -1.02% | – |
| NUVB | Exit | NUVATION BIO INC | $0 | – | -500,000 | -100.0% | -1.17% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -1.20% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -275,000 | -100.0% | -1.51% | – |
| IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -30,000 | -100.0% | -1.56% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -225,000 | -100.0% | -2.27% | – |
| ARKG | Exit | ARK ETF TRput | $0 | – | -200,000 | -100.0% | -4.17% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -150,000 | -100.0% | -11.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.